Loading...

LENSAR, Inc.

LNSR•NASDAQ
Healthcare
Medical - Devices
$12.66
$-0.24(-1.86%)

LENSAR, Inc. (LNSR) Stock Overview

Explore LENSAR, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.3/100

Key Financials

Market Cap151.1M
P/E Ratio-3.07
EPS (TTM)$-4.21
ROE51.79%
Fundamental Analysis

AI Price Forecasts

1 Week$13.06
1 Month$12.67
3 Months$17.98
1 Year Target$16.66

LNSR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LENSAR, Inc. (LNSR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.57, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $16.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.07 and a market capitalization of 151.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.69%
5-Day Change
-4.35%
1-Month Change
3.32%
3-Month Change
62.42%
6-Month Change
161.72%
Year-to-Date (YTD) Change
54.20%
1-Year Change
326.75%
3-Year Change
76.32%
5-Year Change
48.89%
All-Time (Max) Change
48.89%

Contact Information

https://www.lensar.com
888 536 7271
2800 Discovery Drive, Orlando, FL, 32826

Company Facts

140 Employees
IPO DateOct 2, 2020
CountryUS
Actively Trading

Frequently Asked Questions

;